Issue 2/2019
Content (10 Articles)
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Joachim Brumberg, Johannes Tran-Gia, Constantin Lapa, Ioannis U. Isaias, Samuel Samnick
Usefulness of both PET/CT with F18-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report
Hiroto Sasamori, Kimiichi Uno, Jin Wu
Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT
Takayuki Shibutani, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroshi Mori, Shinro Matsuo, Hiroto Yoneyama, Takahiro Konishi, Koichi Okuda, Masahisa Onoguchi, Seigo Kinuya
18F-fluorodeoxyglucose positron emission tomography is correlated with the pathological necrosis and decreased microvessel density in lung adenocarcinomas
Young Wha Koh, Su Jin Lee, Seong Yong Park
Characteristics of iodine-123 IQ-SPECT/CT imaging compared with conventional SPECT/CT
Takayuki Shibutani, Masahisa Onoguchi, Hiroto Yoneyama, Takahiro Konishi, Shinro Matsuo, Kenichi Nakajima
Negative remnant 99mTc-pertechnetate uptake predicts excellent response to radioactive iodine therapy in low- to intermediate-risk differentiated thyroid cancer patients who have undergone total thyroidectomy
Wei Lan, Zhao Gege, Lv Ningning, Wen Qiang, Bai Lin, Ma Qingjie, Ji Bin
Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies
Akira Joraku, Kentaro Hatano, Koji Kawai, Shuya Kandori, Takahiro Kojima, Nobuyoshi Fukumitsu, Tomonori Isobe, Yutaro Mori, Muneyuki Sakata, Tadashi Hara, Katsuhiro Nasu, Manabu Minami, Yuichi Iizumi, Hiroyuki Nishiyama
An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy
Joon Ho Choi, Ilhan Lim, Inki Lee, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang Moo Lim
[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT
Shan Zheng, Zhenying Chen, Chao Huang, Yun Chen, Weibing Miao